Trial · NCT03023592
Study of Iguratimod in Sjögren's Syndrome
NCT03023592, Phase 1, Phase 2, Unknown, Peking Union Medical College Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Study of Iguratimod in Sjögren's Syndrome. Trials, record NCT03023592. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03023592
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Study of Iguratimod in Sjögren's Syndrome
- NCT number
- NCT03023592
- Status
- Unknown
- Phases
- Phase 1, Phase 2
- Enrollment
- 30 participants, estimated
- Lead sponsor
- Peking Union Medical College Hospital
- Conditions
- Sjogren's Syndrome
- Interventions
- Iguratimod
- First posted
- 2017-01-18
- Last updated
- 2017-01-18
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | ESSDAI improvement | week 24 | The change from baseline in ESSDAI (EULAR Sjogren's Syndrome Disease Activity Index) score at 24 weeks. |
| Primary | ESSPRI improvement | week 24 | The change from baseline in ESSPRI (EULAR Sjogren's Syndrome Patient Reported Index) score at 24 weeks. |
| Secondary | Unstimulated salivary flow rate | week 24 | The change from baseline in unstimulated salivary flow rate at 24 weeks. |
| Secondary | Schimer's test | week 24 | The change from baseline in Schimer's test at 24 weeks. |
| Secondary | SF-36 | week 24 | The change from baseline in SF-36 score at 24 weeks. |
| Secondary | HAQ | week 24 | The change from baseline in HAQ score at 24 weeks. |
| Secondary | Immunoglobulins | week 24 | The change from baseline in IgG, IgM and IgA levels at 24 weeks. |
| Secondary | Rheumatoid Factors | week 24 | The change from baseline in titer of rheumatoid factors at 24 weeks. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03023592
GET https://conductscience.org/api/trials/v1/NCT03023592/registered